XRTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
XORTX Therapeutics Inc (XRTX) is not a good buy for a beginner investor with a long-term horizon and $50,000-$100,000 available for investment. The stock shows no strong technical or fundamental indicators of growth, lacks positive catalysts, and has poor financial performance. Additionally, there are no proprietary trading signals or significant trading trends to suggest a buying opportunity.
The technical indicators are bearish. The MACD histogram is negative and contracting, the RSI is neutral at 22.298, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its key support level of 0.39, with resistance levels at 0.416 and 0.442. Historical patterns suggest a 70% chance of declining further in the short to medium term.
NULL identified. No recent news, no significant insider or hedge fund activity, and no AI or SwingMax trading signals.
The stock is in a bearish technical trend with a high probability of further decline (-2.54% in the next week and -6.59% in the next month). Financial performance is weak, with negative net income and declining EPS (-35% YoY).
In Q3 2025, revenue remained at 0 with no growth YoY. Net income improved slightly but remains negative at -649,469 (up 10.64% YoY). EPS dropped significantly by -35% YoY to -0.13. Gross margin is 0, indicating no profitability.
No analyst rating or price target data available.
